Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Chronic Hepatitis E is associated with cholangitis.

Beer A, Holzmann H, Pischke S, Behrendt P, Wrba F, Schlue J, Drebber U, Neudert B, Halilbasic E, Kreipe H, Lohse A, Sterneck M, Wedemeyer H, Manns M, Dienes HP.

Liver Int. 2019 Oct;39(10):1876-1883. doi: 10.1111/liv.14137. Epub 2019 Jun 17.

PMID:
31102493
2.

Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers.

Sandmann L, Dörge P, Wranke A, Vermehren J, Welzel TM, Berg CP, Grottenthaler JM, Weiss KH, Langel J, Sterneck M, von Wulffen M, Manns MP, Wedemeyer H, Hardtke S, von Hahn T.

Eur J Gastroenterol Hepatol. 2019 Aug;31(8):1049-1056. doi: 10.1097/MEG.0000000000001386.

PMID:
30807443
3.

Impact of TBX21, GATA3, and FOXP3 gene polymorphisms on acute cellular rejection after liver transplantation.

Thude H, Tiede P, Sterneck M, Nashan B, Koch M.

HLA. 2019 Feb;93(2-3):97-101. doi: 10.1111/tan.13458. Epub 2019 Jan 18.

PMID:
30614205
4.

Endoscopic retrograde cholangiography and percutaneous transhepatic cholangiodrainage in biliary strictures after liver transplantation: Long-term outcome predictors and influence on patient survival.

Heinemann M, Tafrishi B, Pischke S, Fischer L, Rösch T, Lohse AW, Sterneck M, Denzer UW.

Liver Int. 2019 Jun;39(6):1155-1164. doi: 10.1111/liv.13995. Epub 2019 Feb 21.

PMID:
30367552
5.

Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany.

Herzer K, Gerken G, Kroy D, Tacke F, Plewe J, Eurich D, Spengler U, Strassburg CP, Welker MW, Pischke S, Sterneck M, Mehrabi A, Weiss KH, Herber A, Berg T, Zimmermann T, Galle PR, Heinzow H, Schmidt H, Markova A, Serfert Y, Manns MP, Zeuzem S, Wedemeyer H.

J Hepatol. 2018 Oct;69(4):982-984. doi: 10.1016/j.jhep.2018.07.001. Epub 2018 Aug 6. No abstract available.

PMID:
30089577
6.

Editorial: transplantation in the setting of acute-on-chronic liver failure-calculating chances. Authors' reply.

Huebener P, Sterneck M, Fuhrmann V.

Aliment Pharmacol Ther. 2018 Jul;48(1):100-101. doi: 10.1111/apt.14804. No abstract available.

PMID:
29882978
7.

Alcohol Biomarkers in Clinical and Forensic Contexts.

Andresen-Streichert H, Müller A, Glahn A, Skopp G, Sterneck M.

Dtsch Arztebl Int. 2018 May 4;115(18):309-315. doi: 10.3238/arztebl.2018.0309. Review.

8.

Limited impact of pre-existing donor specific HLA-antibodies (DSA) on long term allograft survival after first adult liver transplantation.

Koch M, Marget M, Sterneck M, Fischer L, Thude H, Nashan B.

Hum Immunol. 2018 Jul;79(7):545-549. doi: 10.1016/j.humimm.2018.04.009. Epub 2018 Apr 15.

PMID:
29669260
9.

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival.

Huebener P, Sterneck MR, Bangert K, Drolz A, Lohse AW, Kluge S, Fischer L, Fuhrmann V.

Aliment Pharmacol Ther. 2018 Jun;47(11):1502-1510. doi: 10.1111/apt.14627. Epub 2018 Apr 2.

PMID:
29611203
10.

Outcome and natural course of renal dysfunction in liver transplant recipients with severely impaired kidney function prior to transplantation.

Horvatits T, Pischke S, Proske VM, Fischer L, Scheidat S, Thaiss F, Fuhrmann V, Lohse AW, Nashan B, Sterneck M.

United European Gastroenterol J. 2018 Feb;6(1):104-111. doi: 10.1177/2050640617707089. Epub 2017 Apr 21.

11.

Long-term follow-up after full-split liver transplantation and its applicability in the recent transplant era.

Herden U, Fischer L, Sterneck M, Grabhorn E, Nashan B.

Clin Transplant. 2018 Mar;32(3):e13205. doi: 10.1111/ctr.13205. Epub 2018 Feb 10.

PMID:
29345754
12.

The killer cell lectin-like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantation.

Thude H, Rother S, Sterneck M, Klempnauer J, Nashan B, Schwinzer R, Koch M.

HLA. 2018 Jan;91(1):52-55. doi: 10.1111/tan.13172.

PMID:
29111570
13.

Chronic pancreatitis in patients with liver cirrhosis negatively affects graft survival after liver transplantation.

Wehmeyer MH, Dammermann W, Seiz O, Zinser ME, Galante A, Lohse AW, Sterneck M, Nashan B, Herden U, Lüth S.

Pancreatology. 2017 Nov - Dec;17(6):898-904. doi: 10.1016/j.pan.2017.09.006. Epub 2017 Sep 14.

PMID:
28939443
14.

Transplanting HCV-Infected Kidneys into Uninfected Recipients.

Halleck F, Budde K, Duerr M, Staeck O, Hofmann J, Eisenberger U, Herzer K, Sterneck M, Gottlieb J, Schulz U.

N Engl J Med. 2017 Sep 14;377(11):1103-4. doi: 10.1056/NEJMc1709315. No abstract available.

PMID:
28902583
15.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J, Eksteen B, Ellinghaus D, Färkkilä M, Festen EAM, Floreani A, Franceschet I, Gotthardt DN, Hirschfield GM, Hoek BV, Holm K, Hohenester S, Hov JR, Imhann F, Invernizzi P, Juran BD, Lenzen H, Lieb W, Liu JZ, Marschall HU, Marzioni M, Melum E, Milkiewicz P, Müller T, Pares A, Rupp C, Rust C, Sandford RN, Schramm C, Schreiber S, Schrumpf E, Silverberg MS, Srivastava B, Sterneck M, Teufel A, Vallier L, Verheij J, Vila AV, Vries B, Zachou K; International PSC Study Group, The UK PSC Consortium, Chapman RW, Manns MP, Pinzani M, Rushbrook SM, Lazaridis KN, Franke A, Anderson CA, Karlsen TH, Ponsioen CY, Weersma RK.

Gut. 2018 Aug;67(8):1517-1524. doi: 10.1136/gutjnl-2016-313598. Epub 2017 Aug 4.

16.

Polymorphisms of the human platelet antigen-1, -2, -3, -5, and -15 systems and acute cellular liver transplant rejection.

Thude H, Bischoff W, Sterneck M, Marget M, Nashan B, Koch M.

Hum Immunol. 2017 Sep;78(9):534-539. doi: 10.1016/j.humimm.2017.07.004. Epub 2017 Jul 10.

PMID:
28705752
17.

Factors associated with long-term survival after liver transplantation: A retrospective cohort study.

Pischke S, Lege MC, von Wulffen M, Galante A, Otto B, Wehmeyer MH, Herden U, Fischer L, Nashan B, Lohse AW, Sterneck M.

World J Hepatol. 2017 Mar 18;9(8):427-435. doi: 10.4254/wjh.v9.i8.427.

18.

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.

Forns X, Berenguer M, Herzer K, Sterneck M, Donato MF, Andreone P, Fagiuoli S, Cieciura T, Durlik M, Calleja JL, Mariño Z, Shukla U, Verbinnen T, Lenz O, Ouwerkerk-Mahadevan S, Peeters M, Janssen K, Kalmeijer R, Jessner W.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12696. Epub 2017 May 4.

PMID:
28295849
19.

Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study.

Andresen-Streichert H, Beres Y, Weinmann W, Schröck A, Müller A, Skopp G, Pischke S, Vettorazzi E, Lohse A, Nashan B, Sterneck M.

Transpl Int. 2017 Jun;30(6):611-620. doi: 10.1111/tri.12949. Epub 2017 Apr 17.

20.

High clinical manifestation rate in an imported outbreak of hepatitis E genotype 1 infection in a German group of travellers returning from India.

Pischke S, Schulze-Zur-Wiesch J, Lütgehetmann M, Kreuels B, Lueth S, Kapaun P, Benten D, Schmiedel S, Sterneck M, Lohse AW, Polywka S.

Ann Hepatol. 2017 Jan-Feb;16(1):57-62. doi: 10.5604/16652681.1226815.

21.

High Clinical Manifestation Rate in an Imported Outbreak of Hepatitis E Genotype 1 Infection in a German Group of Travellers Returning from India.

Pischke S, Schulze-Zur-Wiesch J, Lütgehetmann M, Kreuels B, Lueth S, Kapaun P, Benten D, Schmiedel S, Sterneck M, Lohse AW, Polywka S.

Ann Hepatol. 2017 Jan - Feb;16(1):57-62. doi: 10.5604/16652681.1226815.

22.

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.

Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, Kumasaka N, Atkinson EJ, Schlicht EM, Liu JZ, Shah T, Gutierrez-Achury J, Boberg KM, Bergquist A, Vermeire S, Eksteen B, Durie PR, Farkkila M, Müller T, Schramm C, Sterneck M, Weismüller TJ, Gotthardt DN, Ellinghaus D, Braun F, Teufel A, Laudes M, Lieb W, Jacobs G, Beuers U, Weersma RK, Wijmenga C, Marschall HU, Milkiewicz P, Pares A, Kontula K, Chazouillères O, Invernizzi P, Goode E, Spiess K, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Floreani A, Gulamhusein AF, Eaton JE, Schreiber S, Coltescu C, Bowlus CL, Luketic VA, Odin JA, Chopra KB, Kowdley KV, Chalasani N, Manns MP, Srivastava B, Mells G, Sandford RN, Alexander G, Gaffney DJ, Chapman RW, Hirschfield GM, de Andrade M; UK-PSC Consortium; International IBD Genetics Consortium; International PSC Study Group, Rushbrook SM, Franke A, Karlsen TH, Lazaridis KN, Anderson CA.

Nat Genet. 2017 Feb;49(2):269-273. doi: 10.1038/ng.3745. Epub 2016 Dec 19.

23.

14-bp ins/del polymorphism and +3142C>G SNP of the HLA-G gene have a significant impact on acute rejection after liver transplantation.

Thude H, Janssen M, Sterneck M, Nashan B, Koch M.

Hum Immunol. 2016 Dec;77(12):1159-1165. doi: 10.1016/j.humimm.2016.09.009. Epub 2016 Sep 21.

PMID:
27664842
24.

[Expert recommendations: Hepatitis C and transplantation].

Zimmermann T, Beckebaum S, Berg C, Berg T, Braun F, Eurich D, Herzer K, Neumann U, Rupp C, Sterneck M, Strassburg C, Welker MW, Zachoval R, Gotthardt DN, Weigand K, Schmidt H, Wedemeyer H, Galle PR, Zeuzem S, Sarrazin C.

Z Gastroenterol. 2016 Jul;54(7):665-84. doi: 10.1055/s-0042-107360. Epub 2016 Jul 18. German.

PMID:
27429106
25.

Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study.

Sterneck M, Kaiser GM, Heyne N, Richter N, Rauchfuss F, Pascher A, Schemmer P, Fischer L, Klein CG, Nadalin S, Lehner F, Settmacher U, Gotthardt D, Loss M, Ladenburger S, Wimmer P, Dworak M, Schlitt HJ.

Clin Transplant. 2016 Jun;30(6):741-8. doi: 10.1111/ctr.12744. Epub 2016 May 10.

PMID:
27160359
26.

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation.

Ciesek S, Proske V, Otto B, Pischke S, Costa R, Lüthgehetmann M, Polywka S, Klempnauer J, Nashan B, Manns MP, von Hahn T, Lohse AW, Wedemeyer H, Mix H, Sterneck M.

Transpl Infect Dis. 2016 Jun;18(3):326-32. doi: 10.1111/tid.12524. Epub 2016 May 10.

PMID:
26988272
27.

Selection and use of immunosuppressive therapies after liver transplantation: current German practice.

Herzer K, Strassburg CP, Braun F, Engelmann C, Guba M, Lehner F, Nadalin S, Pascher A, Scherer MN, Schnitzbauer AA, Zimmermann T, Nashan B, Sterneck M.

Clin Transplant. 2016 May;30(5):487-501. doi: 10.1111/ctr.12708. Epub 2016 Mar 31. Review.

PMID:
26855333
28.

Early Initiation of Everolimus After Liver Transplantation: A Single-Center Experience.

Herden U, Galante A, Fischer L, Pischke S, Li J, Achilles E, Koch M, Nashan B, Sterneck M.

Ann Transplant. 2016 Feb 4;21:77-85.

29.

Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life setting.

Pischke S, Polywka S, Proske VM, Lang M, Jordan S, Nashan B, Lohse AW, Sterneck M.

Transpl Infect Dis. 2016 Feb;18(1):141-5. doi: 10.1111/tid.12475. Epub 2016 Jan 30.

PMID:
26485543
30.

Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.

Hildebrand T, Pannicke N, Dechene A, Gotthardt DN, Kirchner G, Reiter FP, Sterneck M, Herzer K, Lenzen H, Rupp C, Barg-Hock H, de Leuw P, Teufel A, Zimmer V, Lammert F, Sarrazin C, Spengler U, Rust C, Manns MP, Strassburg CP, Schramm C, Weismüller TJ; German PSC Study Group.

Liver Transpl. 2016 Jan;22(1):42-52. doi: 10.1002/lt.24350.

31.

Role of the Fyn -93A>G polymorphism (rs706895) in acute rejection after liver transplantation.

Thude H, Kramer K, Peine S, Sterneck M, Nashan B, Koch M.

Hum Immunol. 2015 Sep;76(9):657-62. doi: 10.1016/j.humimm.2015.09.013. Epub 2015 Sep 25.

PMID:
26407913
32.

Definition of chronic hepatitis E after liver transplant conforms to convention.

Meisner S, Polywka S, Memmler M, Nashan B, Lohse AW, Sterneck M, Pischke S.

Am J Transplant. 2015 Nov;15(11):3011-2. doi: 10.1111/ajt.13428. Epub 2015 Aug 19. No abstract available.

33.

Comparison of autochthonous and imported cases of hepatitis A or hepatitis E.

Hartl J, Kreuels B, Polywka S, Addo M, Luethgehetmann M, Dandri M, Dammermann W, Sterneck M, Lohse AW, Pischke S.

Z Gastroenterol. 2015 Jul;53(7):639-43. doi: 10.1055/s-0034-1399236. Epub 2015 Jul 13.

PMID:
26167693
34.

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.

Galante A, Pischke S, Polywka S, Luetgehethmann M, Suneetha PV, Gisa A, Hiller J, Dienes HP, Nashan B, Lohse AW, Sterneck M.

Transpl Infect Dis. 2015 Aug;17(4):617-22. doi: 10.1111/tid.12411. Epub 2015 Jul 14.

PMID:
26094550
35.

Association of hepatitis E virus and essential cryoglobulinemia?

Pischke S, Polywka S, Haag F, Iking-Konert C, Sterneck M, Lütgehetmann M, Dammermann W, Lüth S, Schirmer JH.

J Clin Virol. 2015 Jun;67:23-4. doi: 10.1016/j.jcv.2015.03.020. Epub 2015 Mar 28. No abstract available.

PMID:
25959152
36.

Determination of Ethyl Glucuronide in Hair for Detection of Alcohol Consumption in Patients After Liver Transplantation.

Andresen-Streichert H, von Rothkirch G, Vettorazzi E, Mueller A, Lohse AW, Frederking D, Seegers B, Nashan B, Sterneck M.

Ther Drug Monit. 2015 Aug;37(4):539-45. doi: 10.1097/FTD.0000000000000160.

PMID:
25525763
37.

Lack of association between CD40 polymorphisms and acute rejection in German liver transplant recipients.

Thude H, Kramer K, Koch M, Peine S, Sterneck M, Nashan B.

Hum Immunol. 2014 Nov;75(11):1123-7. doi: 10.1016/j.humimm.2014.09.024. Epub 2014 Oct 11.

PMID:
25305459
38.

Polymorphism in NFKBIA gene is associated with recurrent acute rejections in liver transplant recipients.

Kramer K, Thye T, Treszl A, Peine S, Koch M, Sterneck M, Nashan B, Thude H.

Tissue Antigens. 2014 Oct;84(4):370-7. doi: 10.1111/tan.12411. Epub 2014 Aug 11.

PMID:
25112903
39.

Association between a gain-of-function variant of PTPN22 and rejection in liver transplantation.

Dullin R, Koch M, Sterneck M, Nashan B, Thude H.

Transplantation. 2015 Feb;99(2):431-7. doi: 10.1097/TP.0000000000000313.

PMID:
25073032
40.

Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection.

Wehmeyer MH, Eißing F, Jordan S, Röder C, Hennigs A, Degen O, Hüfner A, Hertling S, Schmiedel S, Sterneck M, van Lunzen J, Lohse AW, Schulze zur Wiesch J, Lüth S.

BMC Gastroenterol. 2014 May 5;14:87. doi: 10.1186/1471-230X-14-87.

41.

Improvement in gastrointestinal and health-related quality of life outcomes after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant recipients.

Sterneck M, Settmacher U, Ganten T, Sarrazin C, Speidel N, Broering D, Heyne N, Paulus E, Mertens M, Fischer L.

Transplant Proc. 2014 Jan-Feb;46(1):234-40. doi: 10.1016/j.transproceed.2013.09.026.

PMID:
24507058
42.

Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation.

Sterneck M, Kaiser GM, Heyne N, Richter N, Rauchfuss F, Pascher A, Schemmer P, Fischer L, Klein CG, Nadalin S, Lehner F, Settmacher U, Neuhaus P, Gotthardt D, Loss M, Ladenburger S, Paulus EM, Mertens M, Schlitt HJ.

Am J Transplant. 2014 Mar;14(3):701-10. doi: 10.1111/ajt.12615. Epub 2014 Feb 6.

43.

Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates.

Sterneck M, Yegles M, Rothkirch von G, Staufer K, Vettorazzi E, Schulz KH, Tobias N, Graeser C, Fischer L, Nashan B, Andresen-Streichert H.

Liver Int. 2014 Mar;34(3):469-76. doi: 10.1111/liv.12243. Epub 2013 Jul 7.

PMID:
23829409
44.

Analysis of cyclosporin a in hair samples from liver transplanted patients.

Müller A, Jungen H, Iwersen-Bergmann S, Sterneck M, Andresen-Streichert H.

Ther Drug Monit. 2013 Aug;35(4):450-8. doi: 10.1097/FTD.0b013e31828abb1d.

PMID:
23783168
45.

Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients.

Thude H, Schipler AD, Treszl A, Peine S, Koch M, Sterneck M, Nashan B.

Hum Immunol. 2013 Aug;74(8):1041-5. doi: 10.1016/j.humimm.2013.04.021. Epub 2013 Apr 27.

PMID:
23628397
46.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M; UK-PSCSC Consortium, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, Chapman RW, Lazaridis KN; International PSC Study Group, Franke A, Anderson CA, Karlsen TH; International IBD Genetics Consortium.

Nat Genet. 2013 Jun;45(6):670-5. doi: 10.1038/ng.2616. Epub 2013 Apr 21.

47.

Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection.

Logge C, Vettorazzi E, Fischer L, Nashan B, Sterneck M.

Transpl Int. 2013 May;26(5):527-34. doi: 10.1111/tri.12085. Epub 2013 Mar 21.

48.

Transcapsular arterial neovascularization of liver transplants increases the risk of intraoperative bleeding during retransplantation.

Herrmann J, Herden U, Ganschow R, Petersen KU, Schmid F, Derlin T, Koops A, Peine S, Sterneck M, Fischer L, Helmke K.

Transpl Int. 2013 Apr;26(4):419-27. doi: 10.1111/tri.12062. Epub 2013 Jan 25.

49.

High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation.

Staufer K, Fischer L, Seegers B, Vettorazzi E, Nashan B, Sterneck M.

Transpl Int. 2012 Nov;25(11):1158-64. doi: 10.1111/j.1432-2277.2012.01540.x. Epub 2012 Aug 6.

50.

Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.

Ellinghaus D, Folseraas T, Holm K, Ellinghaus E, Melum E, Balschun T, Laerdahl JK, Shiryaev A, Gotthardt DN, Weismüller TJ, Schramm C, Wittig M, Bergquist A, Björnsson E, Marschall HU, Vatn M, Teufel A, Rust C, Gieger C, Wichmann HE, Runz H, Sterneck M, Rupp C, Braun F, Weersma RK, Wijmenga C, Ponsioen CY, Mathew CG, Rutgeerts P, Vermeire S, Schrumpf E, Hov JR, Manns MP, Boberg KM, Schreiber S, Franke A, Karlsen TH.

Hepatology. 2013 Sep;58(3):1074-83. doi: 10.1002/hep.25977. Epub 2013 Jan 17.

PMID:
22821403

Supplemental Content

Loading ...
Support Center